112 related articles for article (PubMed ID: 33822199)
21. Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene.
Manjanatha MG; Lyn-Cook LE; Culp SJ; Beland FA; Heflich RH; Aidoo A
Mutat Res; 1996 Oct; 357(1-2):89-96. PubMed ID: 8876684
[TBL] [Abstract][Full Text] [Related]
22. Role of hormones in mammary cancer initiation and progression.
Russo IH; Russo J
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):49-61. PubMed ID: 10819504
[TBL] [Abstract][Full Text] [Related]
23. The genetic components of susceptibility to breast cancer in the rat.
Shepel LA; Gould MN
Prog Exp Tumor Res; 1999; 35():158-69. PubMed ID: 10377759
[TBL] [Abstract][Full Text] [Related]
24. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
25. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
26. Preferential induction of guanine deletion at 5'-GGGA-3' in rat mammary glands by 2-amino- 1-methyl-6-phenylimidazo[4,5-b]pyridine.
Okochi E; Watanabe N; Shimada Y; Takahashi S; Wakazono K; Shirai T; Sugimura T; Nagao M; Ushijima T
Carcinogenesis; 1999 Oct; 20(10):1933-8. PubMed ID: 10506107
[TBL] [Abstract][Full Text] [Related]
27. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
28. A risk characterization for atrazine: oncogenicity profile.
Stevens JT; Breckenridge CB; Wetzel L
J Toxicol Environ Health A; 1999 Jan; 56(2):69-109. PubMed ID: 9972921
[TBL] [Abstract][Full Text] [Related]
29. Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation.
Iizuka D; Imaoka T; Nishimura M; Kawai H; Suzuki F; Shimada Y
Radiat Res; 2013 Feb; 179(2):151-9. PubMed ID: 23273170
[TBL] [Abstract][Full Text] [Related]
30. Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model.
Löscher W; Mevissen M
Cancer Lett; 1995 Sep; 96(2):175-80. PubMed ID: 7585454
[TBL] [Abstract][Full Text] [Related]
31. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
32. H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer.
Yu M; Snyderwine EG
Carcinogenesis; 2002 Dec; 23(12):2123-8. PubMed ID: 12507937
[TBL] [Abstract][Full Text] [Related]
33. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
[TBL] [Abstract][Full Text] [Related]
34. Prolactin and breast carcinoma.
Smithline F; Sherman L; Kolodny D
N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
[TBL] [Abstract][Full Text] [Related]
35. Induction of mammary neoplasms in the Sprague-Dawley rat by 430keV neutrons and X-rays.
Shellabarger CJ; Chmelevsky D; Kellerer AM
J Natl Cancer Inst; 1980 Apr; 64(4):821-33. PubMed ID: 6928995
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
[TBL] [Abstract][Full Text] [Related]
37. Paternal programming of breast cancer risk in daughters in a rat model: opposing effects of animal- and plant-based high-fat diets.
Fontelles CC; Guido LN; Rosim MP; Andrade Fde O; Jin L; Inchauspe J; Pires VC; de Castro IA; Hilakivi-Clarke L; de Assis S; Ong TP
Breast Cancer Res; 2016 Jul; 18(1):71. PubMed ID: 27456846
[TBL] [Abstract][Full Text] [Related]
38. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
[TBL] [Abstract][Full Text] [Related]
39. Profile of early occurring spontaneous tumors in Han Wistar rats.
Son WC; Bell D; Taylor I; Mowat V
Toxicol Pathol; 2010 Feb; 38(2):292-6. PubMed ID: 20124501
[TBL] [Abstract][Full Text] [Related]
40. Comparative chronic toxicity and carcinogenicity of acrylonitrile by drinking water and oral intubation to Spartan Sprague-Dawley rats.
Johannsen FR; Levinskas GJ
Toxicol Lett; 2002 Jun; 132(3):197-219. PubMed ID: 12044704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
